Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2004-09-15
2008-01-01
Davis, Zinna N. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S252130, C514S318000, C514S341000, C514S352000, C514S617000, C544S124000, C544S360000, C546S193000, C546S272400, C546S309000, C564S156000
Reexamination Certificate
active
07314874
ABSTRACT:
Novel benzamide compounds including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against mammalian factor Xa are described. Compositions containing such compounds are also described. The compounds and compositions are useful in vitro or in vivo for preventing or treating coagulation disorders.
REFERENCES:
patent: 2095619 (1937-10-01), Stoesser
patent: 4514416 (1985-04-01), Fujii et al.
patent: 4912001 (1990-03-01), Kouno et al.
patent: 4971957 (1990-11-01), Tsutsumi et al.
patent: 5569768 (1996-10-01), Boyd et al.
patent: 5576343 (1996-11-01), Nagahara et al.
patent: 5872115 (1999-02-01), Binet et al.
patent: 6140351 (2000-10-01), Arnaiz et al.
patent: 6376515 (2002-04-01), Zhu et al.
patent: 520657 (1972-03-01), None
patent: 077534 (1983-04-01), None
patent: 540 051 (1993-05-01), None
patent: 0 937 711 (1999-08-01), None
patent: 2220206 (1990-01-01), None
patent: 59-181257 (1984-10-01), None
patent: 418675 (1992-07-01), None
patent: 11302177 (1999-11-01), None
patent: 96/28427 (1996-09-01), None
patent: 97/29067 (1997-08-01), None
patent: 98/06694 (1998-02-01), None
patent: 98/09630 (1998-03-01), None
patent: 98/28269 (1998-07-01), None
patent: 98/28282 (1998-07-01), None
patent: 98/57934 (1998-12-01), None
patent: 99/00121 (1999-01-01), None
patent: 99/00126 (1999-01-01), None
patent: 99/00127 (1999-01-01), None
patent: 99/00128 (1999-01-01), None
patent: 99/32477 (1999-07-01), None
patent: WO99/42439 (1999-08-01), None
patent: 00/34237 (2000-06-01), None
patent: 00/34238 (2000-06-01), None
patent: 00/34258 (2000-06-01), None
patent: 00/34260 (2000-06-01), None
patent: 00/34261 (2000-06-01), None
patent: 00/34268 (2000-06-01), None
patent: 00/34269 (2000-06-01), None
patent: 00/39118 (2000-07-01), None
Michael R. Wiley et al., “Structure-Based Design of Potent, Amidine-Derived Inhibitors of Factor Xa: Evaluation of Selectively, Anticoagulant Activity, and Antithrombotic Activity”,J. Med. Chem., vol. 43, pp. 883-899 (2000).
Ying K. Yee et al., “N2-Aroylanthranilamide Inhibitors of Human Factor Xa”,J. Med. Chem., vol. 43, pp. 873-882 (2000).
David K. Herron et al., “1,2-Dibenzamidobenzene Inhibitors of Human Factor Xa”,J. Med. Chem., vol. 43, pp. 859-872 (2000).
W. E. Bachmann et al., “Reduction by Magnesium + Magnesium Halide, XIII. The Reaction Between Epoxy Ketones and Grignard Reagents”,Journal of the American Chemical Society, vol. 56, No. 7, pp. 1559-1560 (1934).
Takashi Keumi et al., “2-(Trifluoromethylsulfonyloxy)pyridine as a Reagent for the Ketone Synthesis from Carboxylic Acids and Aromatic Hydrocarbons”,Bull. Chem. Soc. Jpn., vol. 61, No. 2, pp. 455-459 (1988).
“Dictionary of Organic Compounds, 5th Ed., vol. 5,” Chapman and Hall, New York, NY, US (1982), compounds T-00160, T-00161, T-00162, p. 5119 (1982).
Herbert J. Sipe, Jr. et al., “An Improved Synthesis of Aryl Sulfones”,Synthesis, No. 3, pp. 283-284 (1984).
Richard Kuhn et al., “Addition von Maleinsaure-anhydrid an Polyene. (Uber konjugierte DoppeIbindungen, XIV,”Berichte Der Deutschen Chemischen Gesellschaft, vol. 63, pp. 2662-2679 (1930).
John D. Young et al., “Interannular Interactions in Para-Substituted Diphenylmethane Anion Radicals,”J. Am. Chem. Soc., 94:25, Dec. 1972.
Hitomi Suzuki et al., “Selective Reduction with Lithium Aluminum Hydride/Diphosphorus Tetraiodide. A Mild Conversion of Aromatic Ketones to Parent Hydrocarbons,”Chemistry Letters, pp. 909-910, 1983.
St. Goldschmidt and P. Modderman, “Biphenyl Derivatives II. Basic 4-Biphenyl Compounds,”Recueil, 69, 1109-1117 (1950).
W. F. Cockburn et al., “Molecular Rearrangement of Tertiary Amines. Part I.,”J. Chem. Soc., No. 8, pp. 3340-3346 (1960).
Hamilton, A., “Intra- and Intermolecular Hydrogen Bonding Control of Supermolecular Structure,”NATO ASI Ser., Ser. C. (Computational Approaches In Supramolecular Chemistry) vol. 426, 101-8, (1994).
El-Nagdy, S.,Asian J. Chem. 2(4):368-78 (1990).
Kulkarni,J. Indian Chem. Soc. 61(8):720-1 (1984).
Hey, D.,J. Chem. Soc. 16, 1513-18 (1967).
El-Zanfally, S.,Egypt. J. Pharm. Sci. vol. 17(1), 29-34 (1978).
Bing-Yan Zhu et al.,Annual Reports in Medicinal Chemistry, 35, pp. 83-102 (2000).
Huang Wenrong
Scarborough, deceased Robert M.
Zhang Penglie
Zhu Bing-Yan
Davis Zinna N.
Foley & Lardner LLP
Millennium Pharmaceuticals Inc.
LandOfFree
Benzamides and related inhibitors of factor Xa does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzamides and related inhibitors of factor Xa, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzamides and related inhibitors of factor Xa will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3963954